Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer.

about

Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer.

Item

http://www.wikidata.org/entity/Q49337286

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Comparison of FOLFOX and DOF r ...... with advanced gastric cancer.

@en

Comparison of FOLFOX and DOF r ...... with advanced gastric cancer.

@nl

type

Item

label

Comparison of FOLFOX and DOF r ...... with advanced gastric cancer.

@en

Comparison of FOLFOX and DOF r ...... with advanced gastric cancer.

@nl

prefLabel

Comparison of FOLFOX and DOF r ...... with advanced gastric cancer.

@en

Comparison of FOLFOX and DOF r ...... with advanced gastric cancer.

@nl

P1476

Comparison of FOLFOX and DOF r ...... with advanced gastric cancer.

@en

P2093

Guofang Hu

http://www.w3.org/2001/XMLSchema#string

Jun Guo

http://www.w3.org/2001/XMLSchema#string

Liyan Liu

http://www.w3.org/2001/XMLSchema#string

Mengyao Liu

http://www.w3.org/2001/XMLSchema#string

Xiao Han

http://www.w3.org/2001/XMLSchema#string

Yuan Wang

http://www.w3.org/2001/XMLSchema#string

Zhehai Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Chemotherapy for advanced gastric cancer

Cancer statistics, 2014

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients.

Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer.

Outcomes of modified FOLFOX-6 as first line treatment in patients with advanced gastric cancer in a single institution; retrospective analysis.

A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.

P304

375-381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S149624

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29398919

http://www.w3.org/2001/XMLSchema#string

P932

5775733

http://www.w3.org/2001/XMLSchema#string